|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2005-8-15
|
|
pubmed:abstractText |
Fibroblast growth factor (FGF)-2 is one of the most powerful angiogenic growth factors to be evaluated as an agent for the promotion of angiogenesis. The aim of this study is to investigate whether intratracheal administration of controlled-release FGF-2 microspheres restores pulmonary function in beagle dogs with emphysema.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0012-3692
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
128
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
920-6
|
|
pubmed:meshHeading |
pubmed-meshheading:16100187-Animals,
pubmed-meshheading:16100187-Disease Models, Animal,
pubmed-meshheading:16100187-Dogs,
pubmed-meshheading:16100187-Female,
pubmed-meshheading:16100187-Fibroblast Growth Factor 2,
pubmed-meshheading:16100187-Pulmonary Circulation,
pubmed-meshheading:16100187-Pulmonary Emphysema,
pubmed-meshheading:16100187-Rats,
pubmed-meshheading:16100187-Rats, Wistar
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Fibroblast growth factor-2 induces recovery of pulmonary blood flow in canine emphysema models.
|
|
pubmed:affiliation |
Division of Surgical Oncology, Nagasaki University School of Medicine, Japan. morinos@frontier.kyoto-u.ac.jp
|
|
pubmed:publicationType |
Journal Article
|
